• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥人群新冠康复后症状持续存在。

Persistence of COVID-19 Symptoms after Recovery in Mexican Population.

机构信息

Unidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.

Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Jardín Juarez 147, Centro, Zacatecas 98000, Mexico.

出版信息

Int J Environ Res Public Health. 2020 Dec 14;17(24):9367. doi: 10.3390/ijerph17249367.

DOI:10.3390/ijerph17249367
PMID:33327641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7765113/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是导致冠状病毒病(COVID-19)的罪魁祸首,这是一种高度传染性的传染病,已在全球范围内造成许多人死亡。尽管全球都在努力,但它仍在继续造成巨大损失,并留下了许多我们必须解决的未知数,以便更有效地应对这一大流行病。最近出现的一个问题是,从 COVID-19 中康复后会发生什么。出于这个原因,本研究的目的是确定从 COVID-19 中康复后出现持续症状的风险。这项病例对照研究在墨西哥的一个州进行。最初,通过一份关于他们在接受采访时所出现的症状的问卷,从参与者那里获得数据。最初收集了收集到的数据,以制作一个数据集。然后使用 R 项目工具进行预处理,以消除异常值或缺失数据。最终获得了总共 219 名参与者,141 名康复者和 78 名对照组。置信水平为 90%,误差幅度为 7%。结果表明,所有症状在康复者中都存在相关风险。选定症状在康复患者中的相对风险从 3 到 22 倍不等,由于在接受采访时没有对照组出现呼吸困难症状,因此呼吸困难的相对风险为无限,其次是恶心和嗅觉丧失,相对风险为 8.5。因此,必须重新思考公共卫生策略,以治疗或康复患者,避免 COVID-19 康复患者出现慢性问题。

相似文献

1
Persistence of COVID-19 Symptoms after Recovery in Mexican Population.墨西哥人群新冠康复后症状持续存在。
Int J Environ Res Public Health. 2020 Dec 14;17(24):9367. doi: 10.3390/ijerph17249367.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
4
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
6
Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.沙特 COVID-19 患者持续性嗅觉丧失和味觉丧失相关因素的调查。
Int J Environ Res Public Health. 2022 Jan 18;19(3):1047. doi: 10.3390/ijerph19031047.
7
Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.持续性 COVID-19 症状的临床特征:初级保健中的描述性观察研究。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231208283. doi: 10.1177/21501319231208283.
8
Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.预测严重有症状的实验室确诊 SARS-CoV-2 再感染的因素。
Public Health. 2021 Apr;193:113-115. doi: 10.1016/j.puhe.2021.01.021. Epub 2021 Feb 12.
9
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19.新冠肺炎治愈患者鼻咽拭子再次阳性的预测因素。
Am J Prev Med. 2021 Jan;60(1):13-19. doi: 10.1016/j.amepre.2020.08.014. Epub 2020 Sep 18.
10
Social Distance in COVID-19: Drawing the line between protective behavior and stigma manifestation.新冠疫情期间的社交距离:在保护行为和污名表现之间划清界限。
Psychiatriki. 2021 Sep 20;32(3):183-186. doi: 10.22365/jpsych.2021.025. Epub 2021 Aug 5.

引用本文的文献

1
How Are Brain Fog Symptoms Related to Diet, Sleep, Mood and Gastrointestinal Health? A Cross-Sectional Study.脑雾症状与饮食、睡眠、情绪和胃肠道健康有何关联?一项横断面研究。
Medicina (Kaunas). 2025 Feb 15;61(2):344. doi: 10.3390/medicina61020344.
2
Exploring metabolic anomalies in COVID-19 and post-COVID-19: a machine learning approach with explainable artificial intelligence.探索新冠病毒感染期及感染后代谢异常:一种基于可解释人工智能的机器学习方法
Front Mol Biosci. 2024 Sep 9;11:1429281. doi: 10.3389/fmolb.2024.1429281. eCollection 2024.
3
Outcomes and Clinical Profiles of Health Care Workers who Recovered from COVID-19: A Cross-sectional Study on Follow-up and Post-COVID-19 Syndrome.

本文引用的文献

1
Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.病例报告:成人新冠后多系统炎症综合征和血栓性微血管病。
Front Immunol. 2021 Jun 23;12:680567. doi: 10.3389/fimmu.2021.680567. eCollection 2021.
2
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.感染 SARS-CoV-2 后持续疲劳很常见,且与初始感染的严重程度无关。
PLoS One. 2020 Nov 9;15(11):e0240784. doi: 10.1371/journal.pone.0240784. eCollection 2020.
3
[Is there a post-COVID syndrome?].
从新冠病毒肺炎中康复的医护人员的结局与临床特征:一项关于随访及新冠后综合征的横断面研究
Acta Med Philipp. 2024 Jul 31;58(13):76-80. doi: 10.47895/amp.v58i13.8083. eCollection 2024.
4
How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.长新冠患者如何利用新冠疫苗接种和康复服务,以及他们对这些服务的体验如何?一项来自德国的 48 名参与者的定性研究结果。
BMC Public Health. 2024 Mar 28;24(1):915. doi: 10.1186/s12889-024-18380-6.
5
Post-COVID-19 Syndrome and Related Dysautonomia: Reduced Quality of Life, Increased Anxiety and Manifestation of Depressive Symptoms: Evidence from Greece.新冠后综合征及相关自主神经功能障碍:生活质量下降、焦虑增加和抑郁症状表现:来自希腊的证据。
Acta Med Litu. 2023;30(2):139-151. doi: 10.15388/Amed.2023.30.2.6. Epub 2023 Jul 31.
6
Association of long COVID with health-related Quality of Life and Social Participation in Germany: Finding from an online-based cross-sectional survey.德国长期新冠与健康相关生活质量及社会参与的关联:基于网络横断面调查的结果
Heliyon. 2024 Feb 9;10(4):e26130. doi: 10.1016/j.heliyon.2024.e26130. eCollection 2024 Feb 29.
7
Neuropsychiatric manifestations in patients with long COVID in Mexico.墨西哥长期新冠患者的神经精神表现
Brain Circ. 2023 Sep 27;9(3):196-197. doi: 10.4103/bc.bc_13_23. eCollection 2023 Jul-Sep.
8
Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.新型冠状病毒肺炎相关嗅觉障碍的恢复模式:现有证据分析
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4179-4189. doi: 10.1007/s12070-023-04005-8. Epub 2023 Jul 3.
9
A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.急性 SARS-CoV-2 感染后持续性胃肠道症状的患病率和新发胃肠道疾病的发生率的系统评价。
Viruses. 2023 Jul 26;15(8):1625. doi: 10.3390/v15081625.
10
Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients.新冠后综合征与墨西哥重症 COVID-19 患者的生活质量受损。
Front Public Health. 2023 May 15;11:1155951. doi: 10.3389/fpubh.2023.1155951. eCollection 2023.
[存在新冠后综合征吗?]
Pneumologe (Berl). 2020;17(6):398-405. doi: 10.1007/s10405-020-00347-0. Epub 2020 Oct 8.
4
Characteristics of recovered COVID-19 patients with recurrent positive RT-PCR findings in Wuhan, China: a retrospective study.中国武汉新冠病毒核酸检测复阳康复患者的特征:一项回顾性研究
BMC Infect Dis. 2020 Oct 13;20(1):749. doi: 10.1186/s12879-020-05463-z.
5
Short-Term Follow-Up of Self-Isolated COVID-19 Patients with Smell and Taste Dysfunction in Greece: Two Phenotypes of Recovery.希腊新冠病毒自我隔离患者嗅觉和味觉功能障碍的短期随访:两种恢复表型
ORL J Otorhinolaryngol Relat Spec. 2020;82(6):295-303. doi: 10.1159/000511436. Epub 2020 Oct 13.
6
Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center.嗅觉和味觉障碍作为马来西亚一所 tertiary center 中 2019 冠状病毒疾病的临床特征。
Ann Otol Rhinol Laryngol. 2021 May;130(5):513-519. doi: 10.1177/0003489420963165. Epub 2020 Oct 7.
7
Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.在英国伦敦的一个社区人群中,急性嗅觉和/或味觉丧失人群中 SARS-CoV-2 抗体的血清阳性率:一项观察性队列研究。
PLoS Med. 2020 Oct 1;17(10):e1003358. doi: 10.1371/journal.pmed.1003358. eCollection 2020 Oct.
8
Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report.新型冠状病毒肺炎后综合征合并直立性脑灌注不足综合征、小纤维神经病变及免疫治疗的益处:一例报告
eNeurologicalSci. 2020 Dec;21:100276. doi: 10.1016/j.ensci.2020.100276. Epub 2020 Sep 20.
9
Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus.新冠病毒感染后继发炎症综合征,表现为难治性癫痫持续状态。
Epilepsia. 2020 Oct;61(10):e135-e139. doi: 10.1111/epi.16683. Epub 2020 Sep 18.
10
Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies.新冠病毒核糖核酸(RNA)复发的康复新冠患者体内抗受体结合域(RBD)抗体水平较低。
Cell Mol Immunol. 2020 Oct;17(10):1098-1100. doi: 10.1038/s41423-020-00528-0. Epub 2020 Sep 16.